DATABASE

ABCDEFGHIJKLMNOPQRSTUVWXYZ


Name Category
ANAVEX 2-73 shown to block oxidative stress, preventing onset of Alzheimer’s disease News
Anavex appoints Tom Skarpelos as Director News
Anavex comments on FDA plan to expedite approval of new Alzheimer's drugs News
Anavex comments on FDA plan to expedite approval of new Alzheimer’s drugs News
Anavex invited to file funding application for Phase 2a clinical trial of ANAVEX 2-73 News
Anavex Life Sciences Corp. Fund
ANAVEX LIFE SCIENCES CORP. Files SEC form 10-K, Annual Report News
ANAVEX LIFE SCIENCES CORP. Files SEC form 10-Q, Quarterly Report News
ANAVEX LIFE SCIENCES CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equit News
ANAVEX LIFE SCIENCES CORP. Files SEC form 8-K, Termination of a Material Definitive Agreement, Change in Directors or News
ANAVEX LIFE SCIENCES CORP. Financials News
Anavex retains Novak Druce Connolly Bove & Quigg to maximize value of intellectual property portfolio News
Anavex to present at Neuroscience 2012 in New Orleans News
Anaxis Asset Management Company
Anaxis Bond Opportunity 2015 FCP Class U1 Fund
Anaxis Bond Opportunity 2015 FCP Parts -E1- Fund
Anaxis Bond Opportunity 2015 FCP Parts -E2- Fund
Anaxis Bond Opportunity 2015 FCP Parts -U2- 3 Decimales Fund
Anaxis Bond Opportunity 2015 FCP Parts S1 Fund
Anaxis Bond Opportunity 2015 FCP Parts S2 Fund
Anaxis Bond Opportunity US 2017 FCP Parts J Fund
Anaxis Brongniart Flexible Class A Capitalisation Shares (EUR) Fund
Anaxis Brongniart Flexible Class P Capitalisation Fund
Anaxis Brongniart Flexible Shares USD A Capitalisation Fund
Anaxis Fund Sicav-FIS S.A. SICAV-SIF - Anaxis Bond Opportunity l Shs -A- Distributio Fund
Page 585 of 1100